How Wisp Built The Most Complete Women's Health Platform In America
Wisp STI Test
As clinic access shrinks and provider shortages rise, Wisp—the largest pure-play women's telehealth platform in the U.S., available in all 50 states—is betting big on home as the new front line of healthcare. Today, the company launched a diagnostics vertical designed to bring testing and follow-up care for common STIs directly to patients' doors.
With more than 1.5 million users nationwide, Wisp has quietly become a category-defining force in virtual women's health. Its new At-Home Testing & Follow-Up Care service allows patients to collect samples discreetly at home, mail them to CLIA/CAP-accredited labs, and receive results within 3–5 business days—no clinic visit required. All tests include free consultations and, if needed, asynchronous treatment within the Wisp platform.
'We're simplifying the path to complete, 360-degree care, making it possible for patients to access testing and treatment from the comfort of home,' said Monica Cepak, CEO of Wisp.
Wisp's diagnostics offering debuts with three test panels: a Common STI Panel (Chlamydia, Gonorrhea, and Trichomoniasis), a 3-Site Panel (multi-site Chlamydia and Gonorrhea), and an M-Gen Panel (Mycoplasma Genitalium). All tests are processed through CLIA/CAP-accredited labs using non-invasive swab and urine samples.
According to Wisp, 62% of surveyed patients expressed interest in at-home STI testing. The platform's STI, STD, and Herpes categories are up 40% year-over-year.
'We're not just improving convenience—we're helping to destigmatize sexual health and empower patients to take control of their care with confidence,' said Dr. Jillian LoPiano, MD, MPH, FACOG.
Wisp is actively building an interconnected care ecosystem through strategic partnerships:
In March 2025, Wisp launched a comprehensive weight care vertical that includes access to GLP-1 medications for women navigating hormonal imbalances, PCOS, and perimenopause. The offering consists of prescription access, metabolic panels, and support tools to monitor nutritional deficiencies and long-term weight maintenance.
The move positioned Wisp as one of the few platforms approaching GLP-1s from a women's hormonal health lens, not just weight loss.
Wisp also recently launched a first-of-its-kind Male BV Partner Treatment, addressing a longstanding clinical blind spot. The new product provides prescriptions for male partners to prevent reinfection and reduce recurrence rates of BV in female patients.
'This move is about science, empathy, and eliminating recurring frustration for our patients,' said Dr. LoPiano.
In a recent interview with Femtech Insider, Cepak shared how Wisp's lean growth strategy was fueled by SEO and trust, not splashy fundraising. Over 60% of new patients find Wisp through organic search, and the company has remained profitable since before its 2021 acquisition by WELL Health Technologies (Forbes).
'We focused on listening to our customers and solving real problems, faster and more affordably than anyone else,' said Cepak.
Wisp Diagnostics STI Essential 3Panel
Wisp is one of the only DTC platforms offering a fully virtual stack—from diagnostics and treatment to Rx delivery and hormonal health—available in all 50 states.
As Wisp pushes beyond birth control into diagnostics, weight care, and asynchronous treatment, its competitive set reveals a fragmented market—one where most players specialize in narrow verticals, not comprehensive care.
Here's how the landscape stacks up:
Wisp is among a new wave of digital health companies redefining reproductive health branding. In the wake of Roe v. Wade's overturning, the company has embraced direct, unapologetic messaging around sexual health and bodily autonomy.
As reported by The Guardian, Wisp deliberately avoids euphemisms and medical gatekeeping in favor of plainspoken, rights-based language. This strategy is on full display in its award-winning campaign, 'We Heart Healthy Vaginas.'
Created by agency Oberland, the Valentine's Day-themed campaign used playful packaging, reclaimed language, and merch like 'pH-balanced' candy hearts to promote awareness of Wisp's vaginal health offerings. The campaign reached over 30 million impressions and boosted first-time patients.
'We don't want our users to feel like they're entering a hospital portal. We want them to feel seen,' said Cepak. 'Our brand is a promise—not just a product.'
Wisp STI Kit
Founded in 2018 by Matthew Swartz, Wisp scaled without raising traditional VC capital. In 2021, it was acquired by WELL Health Technologies, a Canadian public company focused on digital health platforms.
Though WELL is based in Canada, Wisp serves patients exclusively in the U.S. across all 50 states, with over 1.5 million users and growing.
'Wisp's expansion into diagnostics is a move that reflects our shared vision of building a fully integrated, patient-first healthcare experience. By bringing lab-grade testing into the home and pairing it with accessible virtual care, Wisp is not only enhancing convenience and affordability, but it's redefining what 360-degree care looks like for women.' — Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies
'This launch underscores our founding mission: to put more power, privacy, and choice in the hands of patients,' said Cepak.
As telehealth evolves from transactional visits to full-stack care, Wisp is laying the foundation for an always-on, lifestyle-centric women's health platform. Diagnostics is just the latest step.
From birth control and STI testing to fertility, weight care, and hormonal health, Wisp is building what may become the most complete digital front door for women's health.
Read more on how GLP-1 telehealth models are evolving in this Forbes feature.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
UNM researchers make new discovery about Yellowstone National Park supervolcano
ALBUQUERQUE, N.M. (KRQE) – It's one of the world's largest supervolcanoes, and recent work out of the University of New Mexico led to a breakthrough discovery that could help geoscientists better predict an eruption and save lives. 'So it's very satisfying to see that come to fruition,' said Tobias Fischer, Distinguished Professor of Earth and Planetary Sciences at UNM. Story continues below Crime: Albuquerque business owner faces murder charge for shooting fleeing shoplifter News: Las Vegas deputy charged with aggravated battery and robbery Business: A downtown Albuquerque shoe shine parlor is still serving patrons after nearly a century Events: What's happening around New Mexico May 30-June 5? Kirtland Air Fiesta and more Fischer teamed up with a colleague to investigate Yellowstone National Park's volcanic system. 'Professor Brandon Schmandt is really the person who started this project. He's a geophysicist and he wanted to investigate the composition of the magma and where the magma is under Yellowstone, and especially how much volatiles are in the magma right now,' said Fischer. Fischer said Yellowstone's last volcanic eruption was about 70,000 years ago, and there is still an entire system sitting below the park today. 'So the hydrothermal system has all these beautiful geysers and hot springs and mud pots that attract millions of people a year to see the park and see these features,' said Fischer. Last August, KRQE News 13 reported on a 'localized' hydrothermal explosion that happened at the national park. The team's study led them to look at earthquakes they produced themselves with a big thumper truck. 'With that detailed geophysical study, they can make a very nice CT scan essentially of what's under Yellowstone, and they discovered that there is a really gas-rich, volatile-rich cap on top of the magma chamber,' said Fischer. Fischer said that when volcanoes erupt, they are driven by new magma coming into the system. They use samples from Yellowstone on a machine in one of UNM's labs to learn more. 'As magma rises towards the surface, gases like water and CO2 exalt from that magma at shallower levels,' said Fischer. Those gases migrate up to the surface and then eventually accumulate at some depth. The group found exactly where that accumulation happens, allowing them a better picture at what's taking place right under our feet. 'So it's a very detailed image of the quantity of water, the quantities of pores, the quantities of magma, and where exactly it sits under Yellowstone and how big it is,' said Fischer. Fischer said the Yellowstone system is similar to the Valles Caldera in New Mexico. Although Valles Caldera is smaller, it's a super volcano that produced large eruptions roughly a million years ago. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
14 minutes ago
- Yahoo
Drug maker Indivior to abandon London stock market for the US
Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company to abandon the UK market for the US. However, the LSE welcomes Anglo-American's platinum spin-off Valterra after becoming independent from the mining giant. Indivior's exit comes after the company moved its primary listing to the US's Nasdaq index last year. It said cancelling the secondary listing in London eliminates 'cost and complexity' and better reflects the business – with more than 80% of its revenues generated in the US. It also said liquidity on the Nasdaq now 'far outweighs' that of the LSE with a greater level of trading. The US-based pharmaceutical firm makes prescription medicines to treat opioid addiction, and has a market capitalisation of £1.2 billion. 'A single primary listing on Nasdaq best reflects the profile of Indivior's business,' chairman David Wheadon said. 'We appreciate the support received from shareholders for this initiative and look forward to capitalising on the expected benefits of this move, including reductions in cost and complexity.' The LSE faced the largest exodus of companies since the global financial crisis in 2024, according to EY analysis. There were 88 companies to delist or transfer their primary listing from the main market – the most since 2009. At the same time, the LSE struggled to attract as many new companies to fill the gaps – with 18 new listings in total last year. Nevertheless, Indivior's exit, which will take effect from July 25, comes as Valterra Platinum makes its debut on the London market. Anglo American spun off its platinum business into the new entity, which has become the world's most valuable producer of the metal. Valterra will have its secondary listing on the LSE, with its primary on the Johannesburg Stock Exchange. Duncan Wanblad, Anglo American's chief executive, said: 'Valterra Platinum has been a major part of the company for many years but now is the right time for it to optimise its value creation prospects on an independent path – it's an outstanding business and team and I have every confidence that Valterra Platinum will thrive as a leader in the global platinum group metals industry.' Sign in to access your portfolio
Forbes
19 minutes ago
- Forbes
China Accuses US Of Violating Trade Pact—Rejects Trump's Allegation
Chinese authorities on Monday accused the U.S. of violating a recent trade pact that both agreed to in Geneva last month, as they dismissed President Donald Trump's allegation about Beijing breaching the agreement, a move that could signal a further escalation in trade tensions between the two countries, which could potentially jeopardize last month's tariff truce. China's Commerce Ministry accused the U.S. of violating a trade deal agreed in Geneva by imposing ... More additional chip restrictions and canceling Chinese student visas. In a press briefing, a Chinese Commerce Ministry spokesperson dismissed Trump's comments accusing China of violating the agreement, saying Beijing has worked 'to strictly implement and actively safeguard the Geneva deal.' The spokesperson noted that China had acted in accordance with the deal to cancel or suspend 'relevant tariffs and non-tariff measures' it had taken as retaliation against the U.S. government's reciprocal tariffs. The spokesperson then accused the U.S. of introducing ' a number of discriminatory restrictive measures against China' after the talks, citing expanded export controls on AI chips and other chip-building technology. The official also criticized the U.S. government's crackdown on Chinese student visas, saying these actions violated the consensus reached between Trump and Chinese President Xi Jinping in a phone call on January 17. The spokesperson then warned that if the U.S. continues to take actions that damage China, Beijing will 'take resolute and forceful measures to safeguard its legitimate rights and interests.' In a post on his Truth Social platform on Friday, Trump said: 'China, perhaps not surprisingly to some, HAS TOTALLY VIOLATED ITS AGREEMENT WITH US,' without specifying how it had done so. The president then signalled that the U.S. may retaliate against this alleged non-compliance, saying: 'So much for being Mr. NICE GUY!' In his post, the president claimed his tariffs had put China in 'grave economic danger' and he made a 'FAST DEAL' in Geneva, 'in order to save them from what I thought was going to be a very bad situation.'
